These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6172123)

  • 41. Interferon inhibition of protein synthesis by isolated mitochondria.
    Kortsaris A; Taylor-Papadimitriou J; Georgatsos JG
    Biochem Biophys Res Commun; 1976 Feb; 68(4):1317-22. PubMed ID: 1267779
    [No Abstract]   [Full Text] [Related]  

  • 42. Induction of an antiviral response by interferon requires thymidine kinase.
    Lewis JA; Mengheri E; Esteban M
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):26-30. PubMed ID: 6185957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staurosporine and gossypol are inhibitors of the function of peptide elongation factor 1 alpha from rabbit reticulocytes.
    Tuhácková Z
    Biochem Mol Biol Int; 1994 Mar; 32(3):545-54. PubMed ID: 8032322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of elongation factor 2 associated with native mammalian ribosomes.
    Chinali G; Sacchi A; Ferrini U
    Biochim Biophys Acta; 1982 May; 697(2):193-201. PubMed ID: 7104356
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of interferon action: ability of cloned human type-alpha interferons to induce protein phosphorylation and inhibit virus replication is specified by the host cell rather than the interferon subspecies.
    Samuel CE; Knutson GS; Masters PS
    J Interferon Res; 1982; 2(4):563-74. PubMed ID: 6815285
    [No Abstract]   [Full Text] [Related]  

  • 46. Concerning the mechanism of action of interferon.
    Joklik WK; Merigan TC
    Proc Natl Acad Sci U S A; 1966 Aug; 56(2):558-65. PubMed ID: 5229977
    [No Abstract]   [Full Text] [Related]  

  • 47. Priming of interferon action.
    Fleischmann WR
    Tex Rep Biol Med; 1977; 35():316-25. PubMed ID: 616670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased activity of the eEF-2 specific, Ca2+ and calmodulin dependent protein kinase III during the S-phase in Ehrlich ascites cells.
    Calberg U; Nilsson A; Skog S; Palmquist K; Nygård O
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1372-6. PubMed ID: 1659415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.
    Wreschner DH; James TC; Silverman RH; Kerr IM
    Nucleic Acids Res; 1981 Apr; 9(7):1571-81. PubMed ID: 6164990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Location of enhanced ribonuclease activity and of a phosphoprotein kinase in interferon-treated mengovirus-infected cells.
    Aujean O; Sanceau J; Falcoff E; Falcoff R
    Virology; 1979 Jan; 92(2):583-6. PubMed ID: 218359
    [No Abstract]   [Full Text] [Related]  

  • 51. Methods and procedures for experiments with mixed cell populations: transfer of the antiviral state induced by interferon.
    Blalock JE
    Methods Enzymol; 1981; 79(Pt B):353-9. PubMed ID: 6173683
    [No Abstract]   [Full Text] [Related]  

  • 52. Recovery by interferon of mengovirus-induced shutoff of host protein synthesis.
    Falcoff R; Sancéau J; Aujean O; Vaquero C
    Ann N Y Acad Sci; 1980; 350():522-32. PubMed ID: 6165301
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanism of interferon action: inhibition of pppA(2'p5'A)n-dependent ribonucleases activity in micrococcal nuclease-treated mouse L cell-free extracts.
    Miyamoto NG; Samuel CE
    Biochem Biophys Res Commun; 1981 Jul; 101(2):680-8. PubMed ID: 6171274
    [No Abstract]   [Full Text] [Related]  

  • 54. Human interferon and cell growth inhibition. III. Separation of activities by treatment with sodium dodecyl sulphate.
    Dahl H
    Biochem Biophys Res Commun; 1978 May; 82(1):6-12. PubMed ID: 666848
    [No Abstract]   [Full Text] [Related]  

  • 55. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis.
    Roberts WK; Hovanessian A; Brown RE; Clemens MJ; Kerr IM
    Nature; 1976 Dec; 264(5585):477-80. PubMed ID: 1004583
    [No Abstract]   [Full Text] [Related]  

  • 56. Assay of interferon-mediated protein kinase activity from plasma and tissue extracts.
    Hovanessian AG; Rivière Y; Krust B
    Anal Biochem; 1983 Mar; 129(2):349-56. PubMed ID: 6189422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of two protein kinases associated with the surface membranes of L-929 cells.
    Patterson CL; Brown JC
    Arch Biochem Biophys; 1982 Oct; 218(1):240-8. PubMed ID: 7149732
    [No Abstract]   [Full Text] [Related]  

  • 58. Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells.
    Hovanessian AG; Rollin P; Rivière Y; Pouillart P; Sureau P; Montagnier L
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1371-7. PubMed ID: 6174129
    [No Abstract]   [Full Text] [Related]  

  • 59. Interferon-Sepharose: induction of the antiviral state.
    Knight E
    Biochem Biophys Res Commun; 1974 Feb; 56(4):860-4. PubMed ID: 4826467
    [No Abstract]   [Full Text] [Related]  

  • 60. Double-stranded RNA-dependent phosphorylation of protein P1 and eukaryotic initiation factor 2 alpha does not correlate with protein synthesis inhibition in a cell-free system from interferon-treated mouse L cells.
    Jacobsen H; Epstein DA; Friedmann RM; Safer B; Torrence PF
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):41-5. PubMed ID: 6185959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.